#币安LaunchpoolBIO

pump science: A DeSci funding platform sponsored by the Solana Foundation

In September of this year, the Solana Foundation provided a grant to Molecule, a company founded by the co-founder of BIO Protocol, to build the Solana-based DeSci funding platform pump.science, established on Pump.fun.

Currently, two experimental studies are underway on the pump.science platform, which are:

Rifampicin (RIF)

Urolithin A (URO)

Both of these experiments are currently in the fruit fly testing stage.

RIF is an important antibiotic primarily used to treat bacterial infections such as tuberculosis, Mycobacterium avium complex, leprosy, and legionnaires' disease. Research has found that it can activate the natural defense mechanisms of cells in tiny organisms like Caenorhabditis elegans, helping to resist stress and damage.

URO is a compound produced by the human body after digesting foods rich in ellagitannins, such as pomegranates. Its main function is to promote mitochondrial autophagy, which means clearing out aging and dysfunctional mitochondria to provide growth space for new, healthy mitochondria. Human studies have shown that this substance holds promise in improving muscle health and enhancing energy levels.